The Citadel founder says that the US will lose out on international trade and the AI arms race as a result.
Hedge fund Citadel has made a £305mn bet against drugmaker GSK, the biggest short position against the company in more than a decade.
Citadel CEO Ken Griffin spoke out at the UBS Financial Services conference in Key Biscayne, Fla., on Tuesday, thanking Elon ...
3don MSN
Citadel CEO Ken Griffin sent a stern warning Tuesday against the negative impact from President Donald Trump’s combative ...
Billionaire Ken Griffin's hedge fund Citadel has taken a short position in British drugmaker GSK , the Financial Times ...
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/106.Ckjk1Vbt.js ...
"Tariffs are what you do in the death throes of a nation," Griffin said at a conference outside Miami.
Ken Griffin, founder and CEO of investment firm Citadel, said on Tuesday that U.S. President Donald Trump's tariff policy is ...
Meet the plugged-in players whom billionaire Ken Griffin is relying on to get Citadel’s new headquarters off the ground ...
Griffin, who voted for Trump but did not donate to his campaign, believes the president's "bombastic rhetoric" on tariffs is ...
Citadel CEO Ken Griffin on Tuesday called aggressive trade talk from the new Trump administration" 'huge mistake," producing ...
(Alliance News) - Hedge fund Citadel has made a GBP305 million bet against pharmaceuticals firm GSK PLC, the biggest short position against the company in more than a decade, according to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results